AAAAAA

   
Results: 1-20 |
Results: 20
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/
Authors: EBERS GC RICE G LESAUX J PATY D OGER J LI DKB BEALL S DEVONSHIRE V HASHIMOTO S HOOGE J KASTRUKOFF L KRIEGER C MEZEI M SELAND P VOROBEYCHI G MORRISON W NELSON J FREEDMAN MS CHRISIE S NELSON R RABINOVITCH H FREEDMAN C HARTUNG HP RIECKMANN P ARCHELOS J JUNG S WEILBACH F FLACHENECKE P SAUER J HOMMES O JONGEN P BROUWER S MCLEOD J POLLARD J NG R SANDBERGWOLLHEIM M KALLEN K NILSSON P EKBERG R LUNDGREN A JADBACK G WIKSTROM J MULTANEN J VALJAKKA M CARTON H LISSOIR F DECLERQ I VIEREN M PEETERS E DUBOIS B DEKEERSMAEKER E VANHERLE A HUGHES RAC SHARRACK B SOUDAIN S PANELIUS M ERALINNA J SOILUHANNINEN M MURTO S MEDAER R BROECKX J VANROOSE E BOGAERS A BLUMHARDT LD EDWARDS S LIU C ORPE V BARNES D SCHWARTZ M STOY N HARRAGHY C BERTELSMANN F UITDEHAAG B NASSERI K CHOFFLON M ROTH S KAPPOS L HUBER S BELLAICHE Y SENN C KING J JUBERT J WHITTEN S NEWSOMDAVIS JM PALACE J LEE M EVANGELOU N PINTO A CAVEY A SINDIC CJM MONTEYNE P VEROUGSTRAETE D VANDOORN PA MOLL W VISSER L WILLEMS M MARTINA I BULJEVAC D LOMAN L BATES D PANDIT D IRVING J RHODES B RIDDEHOUGH A ZHAO GJ WANG X CHENG Y AMMOURY N DUPONT F GALAZKA A HYDE R OLSON M PERNIN MO ABDULAHAD AK HOMMES O NOSEWORTHY J BORDEN E OBRIEN P WOLINSKY J
Citation: Gc. Ebers et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/, Lancet, 352(9139), 1998, pp. 1498-1504
ANTICYTOKINE ANTIBODIES IN BETA-INTERFERON-TREATED PATIENTS
Authors: SIBLEY W PATY D RICE GPA MASUOKA LK
Citation: W. Sibley et al., ANTICYTOKINE ANTIBODIES IN BETA-INTERFERON-TREATED PATIENTS, Neurology, 50(6), 1998, pp. 1930-1931
QUANTIFICATION OF CSF SOLUBLE CD27 AS A DIAGNOSTIC-TOOL IN MULTIPLE-SCLEROSIS AND HAM TSP/
Authors: LEIDEN RQH PATY D OGER JJF
Citation: Rqh. Leiden et al., QUANTIFICATION OF CSF SOLUBLE CD27 AS A DIAGNOSTIC-TOOL IN MULTIPLE-SCLEROSIS AND HAM TSP/, Neurology, 50(4), 1998, pp. 2079-2079
VALIDATION OF A NEW MULTIPLE-SCLEROSIS CLINICAL OUTCOME MEASURE USINGPATIENT REPORTED QUALITY-OF-LIFE
Authors: MILLER DM FISCHER JS CUTTER G ANDREWS H LAROCCA NG PATY D RITVO P RUDICK RA
Citation: Dm. Miller et al., VALIDATION OF A NEW MULTIPLE-SCLEROSIS CLINICAL OUTCOME MEASURE USINGPATIENT REPORTED QUALITY-OF-LIFE, Neurology, 50(4), 1998, pp. 5115-5115
PATHOLOGICAL ASSOCIATION AND DISSOCIATION OF FUNCTIONAL-SYSTEMS IN MULTIPLE-SCLEROSIS AND HUNTINGTONS-DISEASE
Authors: CLARK CM JACOVA C KLONOFF H KREMER B HAYDEN M PATY D
Citation: Cm. Clark et al., PATHOLOGICAL ASSOCIATION AND DISSOCIATION OF FUNCTIONAL-SYSTEMS IN MULTIPLE-SCLEROSIS AND HUNTINGTONS-DISEASE, Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology, 19(1), 1997, pp. 63-76
ILLNESS-RELATED FACTORS THAT AFFECT MENTAL-HEALTH IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: MILLER D LAROCCA L ANDREWS H FISCHER J PATY D RITVO P
Citation: D. Miller et al., ILLNESS-RELATED FACTORS THAT AFFECT MENTAL-HEALTH IN PATIENTS WITH MULTIPLE-SCLEROSIS, Quality of life research, 6(5), 1997, pp. 9-9
THE MULTIPLE-SCLEROSIS PRISMS STUDY - PREVENTION OF RELAPSES AND DISABILITY BY INTERFERON BETA-1A SUBCUTANEOUSLY IN MULTIPLE-SCLEROSIS
Authors: EBERS GC OGER J PATY D LI D FREEDMAN M HARTUNG HP HOMMES O MCLEOD J SANDBERG M WIKSTROM J CARTON H HUGHES RAC PANCELIUS M MEDAER R BLUMHARDT L BARNES D BERTELSMANN F CHOFFLON M KAPPOS L KING J NEWSOMDAVIS J SINDIC C UITEHAAG B VANDOOM P BATES D DUPONT F GALAZKA A HYDE R PERNIN MO ABDULAHAD A
Citation: Gc. Ebers et al., THE MULTIPLE-SCLEROSIS PRISMS STUDY - PREVENTION OF RELAPSES AND DISABILITY BY INTERFERON BETA-1A SUBCUTANEOUSLY IN MULTIPLE-SCLEROSIS, Annals of neurology, 42(6), 1997, pp. 2-2
THE 5-YEAR RISK OF MS AFTER OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL
Authors: BRODSKY M JAY W JOHNSON P LAMEY D CAIN S WHEELER B LAM B NAZARIAN S NICHOLS J BUCKHOLTS A FORD R ORENGONANIA S MCCRARY J ROLAK L SLIGHT B CHUNG S GROSS R HOWARD A LAI E FRADY P KATZ B FOLTOS C AMBROSIO T CRUZ T HAWKER N SWAHN T BARSNESS D CHRISTKUHN J GAFFNEY M LOEY N BUCKLEY E ANDERSON M VALENTINE G MASSEY E POLLOCK S RADTKE R DUNCAN L PATTERSON D GUY J ZAM S BURKE R FRANCIS A SHAMIS D CHROUSOS G BURT E KATTAH J GOODWIN J ASLAN R LINDEMAN M SULLIVAN L BOBAK P THOMPSON S CORBETT J MUSSER C DONAHUE S FARRELL T JOHNSTONMCNUSSEN P KARDON R MISHRA A NEAHRING R WALL M FOUNTAIN C SAVINO P WARD S DEVLIN N BOSLEY T CANTOR C MCCLOSKEY L SERGOTT R DAVIS A EDWARDS R MORTON D MILLER N MEDURA M PUTZULO C BUCHHOLZ D REICH S REPKA T WEST L TROBE J CASTILLO R CAUDILL C CORNBLATH W MICHAEL B KAUFMAN D HOLLIDAY S BICKERT S FROEHLICH J KOKINAKIS J EGGENBERGER E MYINT S BARRIS M ROSICK E KUPERSMITH M LANGER R ADDESSI A WEINMAN J FROMER E WAHBA S SHULTS W BOLY L BEARDSLEY C DREYER R HERNDON R WILSON R ARENDS J BEAUDRY T SMITH C KUDER D MACKINNON G SMITH S SPARENBURG J TRAN E BECK R MOKE P ZAJAC L BLAIR RC LESTER L GILLESPIE H MISKALA P JUREIDINI F KAHN D MHAMDI M KELTNER J JOHNSON C SPURR J SHAPIRO L HAKIM H CLAUNCH D BEAM D OWENSBY D ANDERSON MA CLEARY P PATY D MOWERY R EVERETT D
Citation: M. Brodsky et al., THE 5-YEAR RISK OF MS AFTER OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL, Neurology, 49(5), 1997, pp. 1404-1413
TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - REPLY
Authors: SIBLEY WA EBERS GC LUBLIN F PATY D REDER A
Citation: Wa. Sibley et al., TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - REPLY, Neurology, 49(2), 1997, pp. 641-642
A ROLE FOR NATURAL-KILLER (NK) CELLS IN THE IMMUNOPATHOGENESIS OF MULTIPLE-SCLEROSIS
Authors: KASTRUKOFF LF MORGAN N ZECCHINI D SATOH J PATY D
Citation: Lf. Kastrukoff et al., A ROLE FOR NATURAL-KILLER (NK) CELLS IN THE IMMUNOPATHOGENESIS OF MULTIPLE-SCLEROSIS, Neurology, 48(3), 1997, pp. 1112-1112
NEUTRALIZING ANTIBODIES IN BETASERON-TREATED MS PATIENTS AND IN-VITROIMMUNE FUNCTION BEFORE TREATMENT
Authors: OGER JJF VOROBEYCHICK G ALFAHIM A AZIZ T EDAN G PATY D
Citation: Jjf. Oger et al., NEUTRALIZING ANTIBODIES IN BETASERON-TREATED MS PATIENTS AND IN-VITROIMMUNE FUNCTION BEFORE TREATMENT, Neurology, 48(3), 1997, pp. 5005-5005
PATTERNS OF COGNITIVE IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS AND THEIR RELATIONSHIP TO NEUROPATHOLOGY ON MAGNETIC-RESONANCE IMAGES
Authors: RYAN L CLARK CM KLONOFF H LI D PATY D
Citation: L. Ryan et al., PATTERNS OF COGNITIVE IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS AND THEIR RELATIONSHIP TO NEUROPATHOLOGY ON MAGNETIC-RESONANCE IMAGES, Neuropsychology, 10(2), 1996, pp. 176-193
EVIDENCE FOR GENETIC-BASIS OF MULTIPLE-SCLEROSIS
Authors: SADOVNICK AD EBERS GC DYMENT DA RISCH NJ BULMAN D RICE GPA HASHIMOTO SA PATY D OGER JJF METZ L BELL R WARREN S HADER W AUTY T NATH A GRAY T OCONNER P NELSON R FREEDMAN M BRUNET D PAULSETH R FRANCIS G DUQUETTE P MURRAY TJ BAHN V PRYSEPHILLIPS W
Citation: Ad. Sadovnick et al., EVIDENCE FOR GENETIC-BASIS OF MULTIPLE-SCLEROSIS, Lancet, 347(9017), 1996, pp. 1728-1730
IFNB IN MS - REPLY
Authors: SIBLEY WA PATY D EBERS G REDER A LUBLIN F
Citation: Wa. Sibley et al., IFNB IN MS - REPLY, Neurology, 47(4), 1996, pp. 1112-1112
MULTIPLE-SCLEROSIS LESIONS DEVELOP ON SERIAL MRIS DURING A REDUCTION IN NATURAL-KILLER (NK) CELL FUNCTIONAL-ACTIVITY
Authors: KASTRUKOFF LF MORGAN N ZECCHINI D SATOH J PATY D
Citation: Lf. Kastrukoff et al., MULTIPLE-SCLEROSIS LESIONS DEVELOP ON SERIAL MRIS DURING A REDUCTION IN NATURAL-KILLER (NK) CELL FUNCTIONAL-ACTIVITY, Neurology, 45(4), 1995, pp. 233-233
A GENETIC-BASIS FOR FAMILIAL AGGREGATION IN MULTIPLE-SCLEROSIS
Authors: EBERS GC SADOVNICK AD RISCH NJ BULMAN D RICE GPA HASHIMOTO SA PATY D OGER JJF METZ L BELL R WARREN S HADER W AUTY T NATH A GRAY T OCONNOR P NELSON R FREEDMAN M BRUNET D PAULSETH R FRANCIS G DUQUETTE P MURRAY TJ BAHN V PRYSEPHILLIPS W
Citation: Gc. Ebers et al., A GENETIC-BASIS FOR FAMILIAL AGGREGATION IN MULTIPLE-SCLEROSIS, Nature, 377(6545), 1995, pp. 150-151
IN-VIVO VISUALIZATION OF MYELIN WATER IN BRAIN BY MAGNETIC-RESONANCE
Authors: MACKAY A WHITTALL K ADLER J LI D PATY D GRAEB D
Citation: A. Mackay et al., IN-VIVO VISUALIZATION OF MYELIN WATER IN BRAIN BY MAGNETIC-RESONANCE, Magnetic resonance in medicine, 31(6), 1994, pp. 673-677
MS COSTAR - A COMPUTERIZED PATIENT RECORD ADAPTED FOR CLINICAL RESEARCH PURPOSES
Authors: PATY D STUDNEY D REDEKOP K LUBLIN F
Citation: D. Paty et al., MS COSTAR - A COMPUTERIZED PATIENT RECORD ADAPTED FOR CLINICAL RESEARCH PURPOSES, Annals of neurology, 36, 1994, pp. 190000134-190000135
MODELS OF COGNITIVE DEFICIT AND STATISTICAL HYPOTHESES - MULTIPLE-SCLEROSIS, AN EXAMPLE
Authors: RYAN L CLARK CM KLONOFF H PATY D
Citation: L. Ryan et al., MODELS OF COGNITIVE DEFICIT AND STATISTICAL HYPOTHESES - MULTIPLE-SCLEROSIS, AN EXAMPLE, Journal of clinical and experimental neuropsychology, 15(4), 1993, pp. 563-577
TRANS-BLOOD-BRAIN-BARRIER ALBUMIN LEAKAGE AND COMPARISONS OF INTRATHECAL IGG SYNTHESIS CALCULATIONS IN MULTIPLE-SCLEROSIS PATIENTS
Authors: SYNDULKO K TOURTELLOTTE WW CONRAD AJ IZQUIERDO G BELENDUK G KASPER B KLATZMAN D MIETLOWSKI W SOLCH S FRANKLIN G BURKS J NELSON L WANGAARD C MCFARLAND H GOODMAN A MCFARLIN D KREBS H MALONI H DEBRONOZO J SCHEINBERG L TRAUGOTT U AISEN M ROBBINS K SIBLEY W LAGUNA J LAGUNA J TROTTER J CLIFORD D SMITH L MCINNIS J ARNASON B ROOS R REDER A ANTEL J AGUIS M MARTIA R HURWITZ B GREENBURG S FREDANE L HERBSTREITH R HURWITZ J JOHNSON K PANITCH H KOSKI CL FISHMAN P HALEY S PETAJAN J BRAY P ROSE J THURMAN D GALSTER W ELLISON G MYERS L NEWTON L WOLINSKY J SEARS ES NATH A WEISBRODT C KASTRUKOFF LF OGER JJ PATY D BAUMHEFNER RW
Citation: K. Syndulko et al., TRANS-BLOOD-BRAIN-BARRIER ALBUMIN LEAKAGE AND COMPARISONS OF INTRATHECAL IGG SYNTHESIS CALCULATIONS IN MULTIPLE-SCLEROSIS PATIENTS, Journal of neuroimmunology, 46(1-2), 1993, pp. 185-192
Risultati: 1-20 |